Clinical Trials Browser

NIH × Glioblastoma × dabrafenib × Clear all

NCT03919071 2026-03-19

Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma

Phase 2 Active not recruiting

Astrocytoma, Glioblastoma, Glioma